The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The baby boomer generation is undoubtedly the most important demographic for most investors to consider, from a sheer size ...
The US plans ... s list of medicines that will be subject to price negotiations over the next year as part of a Biden administration effort to reduce drug costs for the Medicare health program ...
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
At the top of the list is Novo Nordisk's blockbuster diabetes ... the 25 products represent 36% of all Medicare Part D prescription drug costs during that time period, the release said.